Gene targeting using the human Nalm-6 pre-B cell line

BioScience Trends

Volumn 2, Issue 5, 2008, Pages 169-180

  Adachi, Noritaka ^a   Nishijima, Hitoshi ^b,c   Shibahara, Kei ichi ^b,c  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

Gene knockout; Gene targeting; Nalm 6

Indexed keywords

BIOLOGICAL MODEL; CELL LINE; GENE TARGETING; HUMAN; METHODOLOGY; NUCLEOTIDE SEQUENCE; PHASE CONTRAST MICROSCOPY; REVIEW;

BASE SEQUENCE; CELL LINE; GENE TARGETING; HUMANS; MICROSCOPY, PHASE-CONTRAST; MODELS, GENETIC;

EID: 77952306278     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497-1501.
2. Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell 1998; 2:477-484.
3. Hurwitz R, Hozier J, LeBien T, Minowada J, Gajl-Peczalska K, Kubonishi I, Kersey J. Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer 1979; 23:174-180.
4. Adachi N, So S, Iiizumi S, Nomura Y, Murai K, Yamakawa C, Miyagawa K, Koyama H. The human pre-B cell line Nalm-6 is highly proficient in gene targeting by homologous recombination. DNA Cell Biol 2006; 25:19-24.
5. So S, Adachi N, Lieber MR, Koyama H. Genetic interactions between BLM and DNA ligase IV in human cells. J Biol Chem 2004; 279:55433-55442.
6. Wlodarska I, Aventin A, Ingles-Esteve J, Falzetti D, Criel A, Cassiman JJ, Mecucci C, Van den Berghe H, Marynen P. A new subtype of pre-B acute lymphoblastic leukemia with t(5;12)(q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia. Blood 1997; 89:1716-1722.
7. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89:5547-5551.
8. Mortensen RM., Zubiaur M, Neer EJ, Seidman JG. Embryonic stem cells lacking a functional inhibitory G-protein subunit (alpha i2) produced by gene targeting of both alleles. Proc Natl Acad Sci U S A 1991; 88:7036-7040.
9. Hasty P, Rivera-Perez J, Bradley A. The length of homology required for gene targeting in embryonic stem cells. Mol Cell Biol 1991; 11:5586-5591.
10. Merrihew RV, Marburger K, Pennington SL, Roth DB, Wilson JH. High-frequency illegitimate integration of transfected DNA at preintegrated target sites in a mammalian genome. Mol Cell Biol 1996; 16:10-18.
11. Kang YK, Park JS, Lee CS, Yeom YI, Chung AS, Lee KK. Efficient integration of short interspersed elementflanked foreign DNA via homologous recombination. J Biol Chem 1999; 274:36585-36591.
12. Sauer B, Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A 1988; 85:5166-5170.
13. Babineau D, Vetter D, Andrews BJ, Gronostajski RM, Proteau GA, Beatty LG, Sadowski PD. The FLP protein of the 2-micron plasmid of yeast. Purification of the protein from Escherichia coli cells expressing the cloned FLP gene. J Biol Chem 1985; 260:12313-12319.
14. McCarrick JW 3rd, Parnes JR, Seong RH, Solter D, Knowles BB. Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells. Transgenic Res 1993; 2:183-190.
15. Zhang Y, Riesterer C, Ayrall AM, Sablitzky F, Littlewood TD, Reth M. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 1996; 24:543-548.
16. Fujimori A, Tachiiri S, Sonoda E, Thompson LH, Dhar PK, Hiraoka M, Takeda S, Zhang Y, Reth M, Takata M. Rad52 partially substitutes for the Rad51 paralog XRCC3 in maintaining chromosomal integrity in vertebrate cells. EMBO J 2001; 20:5513-5520.
17. Iiizumi S, Nomura Y, So S, Uegaki K, Aoki K, Shibahara K, Adachi N, Koyama H. Simple one-week method to construct gene-targeting vectors: application to production of human knockout cell lines. Biotechniques 2006; 41:311-316.